|
|
MOLECULAR PHENOTYPING IN ALZHEIMER'S DISEASE |
| 1RF1AG053959-01 |
MONTINE, THOMAS J |
NIA |
2016 |
|
|
UNDERSTANDING ALZHEIMER'S DISEASE IN THE CONTEXT OF THE AGING BRAIN |
| 1RF1AG054108-01 |
CUERVO, ANA MARIA |
NIA |
2016 |
|
|
INTERROGATING THE LINK BETWEEN AGING AND AD WITH TEMPORALLY-CONTROLLED TRANSGENES |
| 1RF1AG054160-01 |
JANKOWSKY, JOANNA L |
NIA |
2016 |
|
|
STRESS MENTAL DISORDERS ACCELERATED AGING AND DEMENTIA A 35 YEAR COHORT STUDY |
| 1U01AG052445-01 |
SPIRA, ADAM PETER |
NIA |
2016 |
|
|
DEVELOPMENT OF EP2 RECEPTOR ANTAGONISTS FOR SUPPRESSION OF ALZHEIMER'S NEUROPATHOLOGY |
| 1U01AG052460-01A1 |
GANESH, THOTA |
NIA |
2016 |
|
|
COGNITIVE RESILIENCE TO ALZHEIMER NEUROPATHOLOGIC CHANGES IN THE HONOLULU-ASIA AGING STUDY AND THE NUN STUDY |
| 1UF1AG053983-01 |
WHITE, LON RAY |
NIA |
2016 |
|
|
DESIGN AND DEVELOPMENT OF EXPERIMENTAL THERAPEUTICS |
| 1ZIAAG000311-16 |
GREIG, NIGEL H. |
NIA |
2016 |
|
|
NEUROPROTECTIVE ROLE OF GLP-1 RECEPTOR AGONISTS |
| 1ZIAAG000333-08 |
GREIG, NIGEL H. |
NIA |
2016 |
|
|
RNA-BINDING FACTORS CONTROLLING NEUROGENESIS AND NEURODEGENERATION |
| 1ZIAAG000518-12 |
GOROSPE, MYRIAM |
NIA |
2016 |
|
|
OXIDATIVE DNA DAMAGE AND ITS PROCESSING |
| 1ZIAAG000727-24 |
BOHR, VILHELM A |
NIA |
2016 |
